PRYP4
associated omics dataQ-omics provides the consensus-scored PRYP4 profile across patient tissues and cancer cell-line models. PRYP4 expression is associated with patient survival in 1 of 34 cancer types, with the highest sampling consensus in PCPG.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for PRYP4 — synthetic lethality, tumor antigen, and pembrolizumab response.
View premium →Survival associations
This table summarizes PRYP4 survival associations across molecular data types. PRYP4 RNA expression shows survival associations in the most cancer types (1). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible PRYP4 RNA expression–survival associations across cancer types. High PRYP4 expression shows unfavorable associations in PCPG. The PCPG Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify PCPG as the clearest survival context for PRYP4 RNA expression.
